id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2010-N-0621-0545,FDA,FDA-2010-N-0621,Final Decisions; Availability: Withdrawal of Breast Cancer Indication for AVASTIN (Bevacizumab),Notice,Notice of Availability,2012-02-27T05:00:00Z,2012,2,2012-02-27T05:00:00Z,,2012-02-27T13:42:30Z,2012-04424,0,0,0900006480fc3066